OR WAIT null SECS
L.J. Sellers, senior editor, moved to Pharmaceutical Executive in July 1999 after writing for Pharmaceutical Technology for one year. She acquisitions articles, writes and edits features, including cover profiles, and handles various special projects. Before joining Advanstar, L.J. was a freelance writer and, in addition to numerous magazine articles, has penned four novels and five scripts. Her most recent novel, Beyond Conception, will be available from online bookstores in January 2002.
Straddling the divide between drug discovery and drug delivery, Protarga doesn't fit neatly into any pharma category. It's not exactly a delivery technology company, because its products are patentable new entities that it plans to keep for itself. Nor is it purely biotech, because it works with chemical compounds. And in the end, president and CEO Nigel Webb expects Protarga to become a fully integrated pharma company-but only in the virtual sense.